Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer

Clinical trial NCT05179889 · RECRUITING

Trial details

NCT number: NCT05179889
Sponsor: Chungnam National University Hospital
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Colon Cancer Stage III

Start date: 2021-07-06
Primary completion: 2028-07-05
Enrollment: 308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.